Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 486

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 486
---
 through the “Investors” section of our website at https://channeltherapeutics.com/. Our website address is being provided as an inactive textual reference only. The information provided on, or accessible through, our website, other than the copies of the documents listed or referenced below that have been or will be filed with the SEC, is not part of this information statement, and therefore is not incorporated herein by reference.

<div align='center'>285</div>

#### TABLE OF CONTENTS
We undertake to provide without charge to each person to whom a copy of this information statement has been delivered, upon written or oral request, by first-class mail or other equally prompt means within one business day of receipt of such request, a copy of this information statement. You may request a copy of these filings by writing or telephoning us at the following address:

<div align='center'>Channel Therapeutics Corporation

4400 Route 9 South, Suite 1000

Freehold, NJ 07728

(877) 265-8266</div>

Ligand and LNHC have supplied, and we have not independently verified, the information in this information statement relating to Ligand and LNHC.

Stockholders should not rely on information that purports to be made by or on behalf of us other than that contained in this information statement. We have not authorized anyone to provide information on behalf of us that is different from that contained in this information statement. This information statement is dated May 27, 2025. No assumption should be made that the information contained in this information statement is accurate as of any date other than that date, and the mailing of this information statement will not create any implication to the contrary.

<div align='center'>286</div>

TABLE OF CONTENTS

CHANNEL THERAPEUTICS CORPORATION INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

|                                                                        |     | Page |
| Unaudited Financial Statements                                         |     |      |
| Condensed Consolidated Balance Sheets                                  |     | F-2  |
| Condensed Consolidated Statements of Operations                        |     | F-3  |
| Condensed Consolidated Statements of Changes in Stockholders’ Deficit  |     | F-5  |
| Condensed Consolidated Statements of Cash Flows                        |     | F-6  |
| Notes to the Condensed Consolidated Financial Statements               |     | F-7  |
| Audited Financial Statements                                           |     |      |
| Report of Independent Registered Public Accounting Firm (PCAO